SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-19-002223
Filing Date
2019-02-12
Accepted
2019-02-12 15:41:56
Documents
1
Group Members
ANDREW MARTINKEVIN RUSSELL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G sc13g1218a2ubsoconn_protalix.htm SC 13G/A 76633
  Complete submission text file 0001213900-19-002223.txt   78408
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50118 | Film No.: 19590513
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address ONE NORTH WACKER DRIVE 32ND FLOOR CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE 32ND FLOOR CHICAGO IL 60606 3125256000
UBS OCONNOR LLC (Filed by) CIK: 0001132716 (see all company filings)

IRS No.: 061569842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A